WHO tries to tackle problem of counterfeit medicines in Asia

doi:10.1136/bmj.327.7424.1126-a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Stephen Pincock

London

Experts from the World Health Organization were in Hanoi this week to discuss ways of tackling the problem of counterfeit medicines with officials from countries in Asia's Mekong delta region.

WHO sees the problem of fake or substandard medicines as a serious public health threat in the “greater Mekong subregion,” which includes Vietnam, the Lao People's Democratic Republic, Cambodia, China, Myanmar, and Thailand.

It hopes that the meetings will kick-start efforts to raise awareness among decision makers, health professionals, and the general public and to strengthen inspection and post-marketing surveillance.

Recent WHO estimates suggest that Cambodia has about 2800 illegal medicine sellers and 1000 unregistered medicines …